The role of surgery in the multimodality treatment stage IIIa/N2 NSCLC remains controversial. To assess the oncological outcomes of upfront lung resection and potential prognostic factors, we examined a subset of patients diagnosed with "occult" pN2 NSCLC
Oncological outcomes of upfront surgery in patients with “occult” pathological N2 non-small cell lung cancer: an international multicntre study / E. Prisciandaro, C. Bardoni, D. Tosi, M. Thumerel, L. Spaggiari, M. Nosotti, J. Jougon, L. Bertolaccini. ((Intervento presentato al 30. convegno ESTS Annual Meeting tenutosi a Den Haag : 19-21 Giugno nel 2022.
Oncological outcomes of upfront surgery in patients with “occult” pathological N2 non-small cell lung cancer: an international multicntre study
E. Prisciandaro;C. Bardoni;L. Spaggiari;M. Nosotti;
2022
Abstract
The role of surgery in the multimodality treatment stage IIIa/N2 NSCLC remains controversial. To assess the oncological outcomes of upfront lung resection and potential prognostic factors, we examined a subset of patients diagnosed with "occult" pN2 NSCLC
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ESTS 2022 (Oncological outcomes of upfront surgery...).pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
463.66 kB
Formato
Adobe PDF
|
463.66 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
